CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)

Market Cap	41.33B
Revenue (ttm)	2.04B
Net Income (ttm)	513.13M
Shares Out	1.39B
EPS (ttm)	0.37
PE Ratio	80.54
Forward PE	116.85
Dividend	0.27 (0.90%)
Ex-Dividend Date	Apr 25, 2024

Volume	24,142,248
Average Volume	7,407,264
Open	27.91
Previous Close	26.75
Day's Range	27.02 - 29.98
52-Week Range	21.07 - 37.08
Beta	-0.19
RSI	60.99
Earnings Date	Mar 21, 2025

About SHE:300765

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, Ch...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2006
• Employees: 1,887
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300765

Financial Performance

In 2023, SHE:300765's revenue was 2.50 billion, a decrease of -4.75% compared to the previous year's 2.63 billion. Earnings were 755.56 million, an increase of 4.03%.